Prospective Study of the Role of Transurethral Resection of the Prostate in Patients with an Elevated Prostate-Specific Antigen Level, Minor Lower Urinary Tract Symptoms, and Proven Bladder Outlet Obstruction

European Urology

Volumn 54, Issue 6, 2008, Pages 1385-1392

  van Renterghem, Koenraad ^a   Van Koeveringe, Gommert ^b   Achten, Ruth ^a   van Kerrebroeck, Philip ^b  

^a VIRGA JESSE HOSPITAL   (Belgium)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bladder outlet obstruction; Lower urinary tract symptoms; Prostate biopsy; Prostate cancer; Prostate specific antigen; Transurethral resection of prostate

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER NECK STENOSIS; CLINICAL ARTICLE; DETRUSOR MUSCLE; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; HISTOPATHOLOGY; HUMAN; LOWER URINARY TRACT SYMPTOM; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; QUALITY OF LIFE; TRANSRECTAL ULTRASONOGRAPHY; TRANSURETHRAL RESECTION; URODYNAMICS;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROSTATISM; TRANSURETHRAL RESECTION OF PROSTATE; URINARY BLADDER NECK OBSTRUCTION;

EID: 55649112058     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.06.069     Document Type: Article

References (31)

1. Guichard G., Larré S., Gallina A., et al. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients. Eur Urol 52 (2007) 430-435
2. Djavan B., Ravery V., Zlotta A., et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3, and 4: when should we stop?. J Urol 166 (2001) 1679-1683
3. Laniado M., Ockrim J., Marronaro A., et al. Serum prostate-specific antigen to predict the presence of bladder outlet obstruction in men with urinary symptoms. BJU Int 94 (2004) 1283-1286
4. Van Renterghem K., Van Koeveringe G., and van Kerrebroeck P. Rising PSA in patients with minor LUTS without evidence of prostatic carcinoma: a missing link?. Int Urol Nephrol 39 (2007) 1107-1113
5. Van Renterghem K., Van Koeveringe G., Achten R., and van Kerrebroeck P. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level. Eur Urol 52 (2007) 819-826
6. Berger A., Deibl M., Strasak A., et al. Large-scale study of clinical impact of PSA velocity: long-term PSA kinetics as method of differentiating men with from those without prostate cancer. Urology 69 (2007) 134-138
7. Durkan G.C., Sheikh N., Johnson P., et al. Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol. BJU Int 89 (2002) 33-39
8. Boccon-Gibod L., van der Kwast T.H., Montironi R., et al. Handling and pathology reporting of prosate biopsies. Eur Urol 46 (2004) 177-181
9. Griffiths D., Höfner K., van Mastrigt R., et al. Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and urethral obstruction. Neurourol Urodyn 16 (1997) 1-18
10. Rosai J. Ackerman's surgical pathology. 9th ed. (2004), Mosby, St. Louis, MO
11. Eastham J.A., Kattan M.W., Fearn P., et al. Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate Group. Eur Urol 53 (2008) 347-354
12. Cheng L., Bergstralh E.J., Scherer B.G., et al. Predictors of cancer progression in T1a prostate adenocarcinoma. Cancer 85 (1999) 1300-1304
13. Bratt O. The difficult case in prostate cancer diagnosis-when is a "diagnostic TURP" indicated?. Eur Urol 49 (2006) 769-771
14. Puppo P., Introini C., Calvi P., and Naselli A. Role of transurethral resection of the prostate and biopsy of the peripheral zone in the same session after repeated negative biopsies in the diagnosis of prostate cancer. Eur Urol 49 (2006) 873-878
15. Catalona W.J., Southwick P.C., Slawin K.M., et al. Comparison of percent free PSA, PSA density, and age-specific PSA cut-offs for prostate cancer detection and staging. Urology 56 (2000) 255-260
16. Loeb S., Roehl K.A., Catalona W.J., and Nadler R.B. Prostate-specific antigen velocity threshold for predicting prostate cancer in young men. J Urol 177 (2007) 899-902
17. Arnold P., Niemann T., and Bahnson R. Extended sector biopsy for detection of carcinoma of the prostate. Urol Oncol 6 (2001) 91-93
18. Roehrborn C., McConnell J., Lieber M., et al. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. Urology 53 (1999) 473-480
19. Roehrborn C., McConnell J., Bonilla J., et al. Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. J Urol 163 (2000) 13-20
20. 1-blockers and watchful waiting. J Urol (2004) 300-305
21. European Association of Urology. Guidelines on benign prostatic hyperplasia, section 1.2.2. Available at: http://www.uroweb.org/fileadmin/user_upload/Guidelines/BPH.pdf.
22. Roehrborn C.G. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE. BJU Int 101 Suppl 3 (2008) 17-21
23. Rule A.D., Lieber M.M., and Jacobsen S.J. Is benign prostatic hyperplasia a risk factor for chronic renal failure?. J Urol 173 (2005) 691-696
24. Brawer M.K., Lin D.W., Williford W.O., et al. Effect of finasteride and/or terazosin on serum PSA: results of VA Cooperative Study #359. Prostate 39 (1999) 234-239
25. Noguchi M., Stamey T.A., Neal J.E., and Yemoto C.E. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. J Urol 163 (2000) 1751-1755
26. Teillac P., and Scarpa R.M. Economic issues in the treatment of BPH. Eur Urol Suppl 5 (2006) 1018-1024
27. Wendt-Nordahl G., Bucher B., Häcker A., et al. Improvement in mortality and morbidity in transurethral resection of the prostate over 17 years in a single center. J Endourol 21 (2007) 1081-1087
28. Reich O., Gratzke C., and Stief C.G. Techniques and long-term results of surgical procedures for BPH. Eur Urol 49 (2006) 970-978
29. Madesbacher S., Marszalek M., Lackner J., et al. The long-term outcome of medical therapy for BPH. Eur Urol 51 (2007) 1522-1533
30. Laguna P., and Alivizatos G. Prostate-specific antigen and benign prostatic hyperplasia. Curr Opin Urol 10 (2000) 3-8
31. Colombo R., Naspro R., Salonia A., et al. Radical prostatectomy after previous prostate surgery: clinical and functional outcomes. J Urol 176 (2006) 2459-2463